EP1501496A4

Formulations containing amiodarone and sulfoalkyl ether cyclodextrin

Abstract

This record has no abstract on file.

EP1501496A4, drawing sheet 1 — Sheet 1 of 17

Term

Term ended

Projected expiry passed 29 April 2023, 3.4 years ago.

17 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
US2002012680A1	Cites	United States of America	DX	Search report	1-51
US6046177A	Cites	United States of America	DX	Search report	1-51

32 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims9

Priority claims
Document	Office	Kind	Date
139620	United States of America	–	2002-05-04
13962002	United States of America	A	2002-05-04
13962002	United States of America	A	2002-05-04
0313250	United States of America	W	2003-04-29
0313250	United States of America	W	2003-04-29
139620	–	–	–
US20020139620	–	–	–
US2003013250	–	–	–
WO2003US13250	–	–	–

Members32

Family members, oldest first
Document	Office	Kind
CA2483774A1	Canada	A1	2003-11-13
WO03092590A2	World Intellectual Property Organization (WIPO)	A2	2003-11-13
AU2003234285A1	Australia	A1	2003-11-17
US2003216353A1	United States of America	A1	2003-11-20
WO03092590A3	World Intellectual Property Organization (WIPO)	A3	2004-01-22
KR20040106452A	Republic of Korea	A	2004-12-17
EP1501496A2	European Patent Office (EPO)	A2	2005-02-02
MXPA04010925A	Mexico	A	2005-02-14
US6869939B2	United States of America	B2	2005-03-22
JP2005530744A	Japan	A	2005-10-13
IL165022A0	Israel	A0	2005-12-18
EP1501496A4This record	European Patent Office (EPO)	A4	2006-05-31
AU2003234285B2	Australia	B2	2007-01-04
KR100984197B1	Republic of Korea	B1	2010-09-28
JP2011116776A	Japan	A	2011-06-16
CA2483774C	Canada	C	2011-07-19
IL165022A	Israel	A	2011-08-31
JP4764004B2	Japan	B2	2011-08-31
EP1501496B1	European Patent Office (EPO)	B1	2011-11-30
AT535239T	Austria	T	2011-12-15
ATE535239T1	Austria	T1	2011-12-15
EP2402008A1	European Patent Office (EPO)	A1	2012-01-04
PT1501496E	Portugal	E	2012-02-20
DK1501496T3	Denmark	T3	2012-03-19
ES2378306T3	Spain	T3	2012-04-11
SI1501496T1	Slovenia	T1	2012-04-30
JP5656692B2	Japan	B2	2015-01-21
EP2402008B1	European Patent Office (EPO)	B1	2016-01-27
ES2567716T3	Spain	T3	2016-04-26
DK2402008T3	Denmark	T3	2016-05-02
SI2402008T1	Slovenia	T1	2016-05-31
HUE027551T2	Hungary	T2	2016-10-28

89 legal events, as 18 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2023-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-07-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2023-06-28	Opt-out of the competence of the unified patent court (upc) registeredP01	P01	EP
2023-06-15	ExpiryMK07	MK07	AT
2023-05-30	Ep patent has lapsedLapsedEUG	EUG	SE
2023-05-24	Patent expiredExpiredMK9A	MK9A	IE
2023-05-24	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2023-05-17	Patent expiredExpiredMK4A	MK4A	SK
2023-05-15	Patent ceasedCeasedPL	PL	CH
2023-05-09	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2023-05-09	Patent expired because of reaching the maximum lifetime of a patentExpiredMK	MK	BE
2023-05-03	Patent expired because of reaching the maximum lifetime of a patentExpiredMK	MK	NL
2023-05-01	Ep patent expiredExpiredEUP	EUP	DK
2023-04-29	Expiry of rightR071	R071	DE
2022-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-08-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-07-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-06-01	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-04-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-04-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-04-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2022-04-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2018-03-15	Fee paymentPLFP	PLFP	FR
2017-03-13	Fee paymentPLFP	PLFP	FR
2016-03-09	Fee paymentPLFP	PLFP	FR
2015-04-08	Fee paymentPLFP	PLFP	FR
2012-12-28	Filing of the translation of the text of european patentsAG4A	AG4A	HU
2012-12-27	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2012-11-07	No opposition filedOpposition26N	26N	EP
2012-10-05	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2012-10-05	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2012-06-04	Translation of european patent specification into slovakT3	T3	SK
2012-05-10	Change of applicant/patenteeR081	R081	DE
2012-05-10	Change of applicant/patenteeR081	R081	DE
2012-05-10	Change of applicant/patenteeR081	R081	DE
2012-05-10	Change of applicant/patenteeR081	R081	DE
2012-04-25	Ep patent validated in greeceEP	EP	GR
2012-04-16	Translation of the specification of european patent valid in estoniaFG4A	FG4A	EE
2012-04-11	Definitive protectionFG2A	FG2A	ES
2012-03-20	Translation of granted ep patentGrantedTRGR	TRGR	SE
2012-03-19	Ep patent with danish claimsT3	T3	DK
2012-03-08	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2012-03-07	Party data changed (patent owner data changed or rights of a patent transferred)RAP2	RAP2	EP
2012-02-29	Ep patent valid in romaniaEPE	EPE	RO
2012-02-29	New agentNV	NV	CH
2012-02-29	Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3	T3	NL
2012-02-20	Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A	SC4A	PT
2012-01-04	European patents granted designating irelandGrantedFG4D	FG4D	IE
2011-11-30	Designated contracting statesAK	AK	EP
2011-11-30	European patent takes effect as a national patent in ch/liEP	EP	CH
2011-11-30	European patent grantedGrantedFG4D	FG4D	GB
2011-10-28	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2011-10-25	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2011-05-27	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2008-08-20	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2008-07-23	Party data changed (applicant data changed or rights of an application transferred)RAP1	RAP1	EP
2007-08-29	First examination report despatched17Q	17Q	EP
2006-05-31	Supplementary search report drawn up and despatchedA4	A4	EP
2006-05-31	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2006-05-31	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2006-05-31	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2005-08-24	Request for extension of the european patent (deleted)DAX	DAX	EP
2005-02-02	Request for examination filed17P	17P	EP
2005-02-02	Designated contracting statesAK	AK	EP
2005-02-02	Request for extension of the european patentAX	AX	EP
2004-12-17	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Formulations containing amiodarone and sulfoalkyl ether cyclodextrin

Abstract

Term

Priority claims9

Members32

Over the term

Events

Numbers

Titles3

Classification

Designated states1